Home
William Grossman, Interim Chief Medical Officer: enGene Therapeutics ENGN Buy · Filed 09/24
Trade details
- Type
- Insider buy
- Amount
- $10,050.94
- Shares · price
- 5,102 sh · $1.97 a share
- Held after
- 5,102 sh
- Trade date
- 26/09/22
- Filed
- 26/09/24
- Days to filing
- 2 days
First purchase
- Insiders buying this week
- 1 insiders
enGene Therapeutics trades, last 26 weeks
What else happened in enGene Therapeutics around then
Filed or reported within 30 days of the trade day · 08/23~10/22William Grossman's recent trades
No other trades yet.